» Articles » PMID: 28815354

NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2017 Aug 18
PMID 28815354
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: This study aimed to evaluate the antifibrotic effects of NF-E2-Related Factor 2 (Nrf2) on intestinal fibrosis. Intestinal fibrosis is a common complication of Crohn's disease; however, its mechanism of intestinal fibrosis is largely unclear.

Methods: BALB/c mice received 2,4,6-trinitrobenzene sulfonic acid weekly via intrarectal injections to induce chronic fibrotic colitis. They also diet containing received 1% (w/w) tert-butylhydroquinone (tBHQ), which is an agonist of Nrf2. Human intestinal fibroblasts (CCD-18Co cells) were pretreated with tBHQ or si-Nrf2 followed by stimulation with transforming growth factor-β1 (TGF-β1), which transformed the cells into myofibroblasts. The main fibrosis markers such as α-smooth muscle actin, collagen I, tissue inhibitor of metalloproteinase-1, and TGF-β1/SMADs signaling pathway were detected by quantitative real-time RT-PCR, immunohistochemical analysis, and Western blot analysis. Levels of cellular reactive oxygen species (ROS) were detected by dichlorodihydrofluorescein diacetate.

Results: tBHQ suppressed the intestinal fibrosis through the TGF-β1/SMADs signaling pathway in TNBS-induced colitis and CCD-18Co cells. Moreover, Nrf2 knockdown enhanced the TGF-β1-induced differentiation of CCD-18Co cells. ROS significantly increased in TGF-β1-stimulated CCD-18Co cells. Pretreatment with HO, the primary component of ROS, was demonstrated to block the effect of tBHQ on reducing the expression of TGF-β1. Moreover, scavenging ROS by N-acetyl cysteine could inhibit the increasing expression of TGF-β1 promoted by Nrf2 knockdown.

Conclusions: The results suggested that Nrf2 suppressed intestinal fibrosis by inhibiting ROS/TGF-β1/SMADs pathway in vivo and in vitro.

Citing Articles

Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease.

Yuan L, Wang Y, Li N, Yang X, Sun X, Tian H Antioxidants (Basel). 2024; 13(8).

PMID: 39199256 PMC: 11351392. DOI: 10.3390/antiox13081012.


Inflammation accelerating intestinal fibrosis: from mechanism to clinic.

Xin S, Liu X, He C, Gao H, Wang B, Hua R Eur J Med Res. 2024; 29(1):335.

PMID: 38890719 PMC: 11184829. DOI: 10.1186/s40001-024-01932-2.


Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK/Nrf2 signalling pathway.

Mustafa Badi R, Khaleel E, Satti H, Monir R J Tradit Complement Med. 2024; 14(2):203-214.

PMID: 38481546 PMC: 10927380. DOI: 10.1016/j.jtcme.2023.11.003.


Preventing fibrosis in IBD: update on immune pathways and clinical strategies.

Wang J, Yang B, Chandra J, Ivanov A, Brown J, Rieder F Expert Rev Clin Immunol. 2024; 20(7):727-734.

PMID: 38475672 PMC: 11180587. DOI: 10.1080/1744666X.2024.2330604.


The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis.

Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y Front Immunol. 2023; 14:1200111.

PMID: 37359553 PMC: 10285877. DOI: 10.3389/fimmu.2023.1200111.


References
1.
Maimaiti R, Zhang Y, Pan K, Wubuli M, Andersson R . Frequent coinfection with hepatitis among HIV-positive patients in Urumqi, China. J Int Assoc Provid AIDS Care. 2012; 12(1):58-61. DOI: 10.1177/1545109712446176. View

2.
Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G . Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis. 2014; 8(10):1147-65. DOI: 10.1016/j.crohns.2014.03.008. View

3.
Motohashi H, Yamamoto M . Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10(11):549-57. DOI: 10.1016/j.molmed.2004.09.003. View

4.
Yang Y, Kim B, Park Y, Koo S, Lee J . Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochim Biophys Acta. 2014; 1850(1):178-85. DOI: 10.1016/j.bbagen.2014.10.014. View

5.
Wu H, Li G, Xie J, Li R, Chen Q, Chen J . Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc Disord. 2016; 16:5. PMC: 4707778. DOI: 10.1186/s12872-015-0169-z. View